+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genfit - logo

GENFIT is a biopharmaceutical company that focuses on developing diagnostic solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. Its lead pipeline product elafibranor (GFT505) has recently completed a positive Phase 2b study in NASH (Non-Alcoholic Steato-Hepatitis). Genfit SA was founded in 1999 and is headquartered in Loos, France.

Non-alcoholic Steatohepatitis (NASH) - Global Strategic Business Report - Product Thumbnail Image

Non-alcoholic Steatohepatitis (NASH) - Global Strategic Business Report

  • Report
  • November 2024
  • 179 Pages
  • Global
From
Global Nonalcoholic Steatohepatitis (NASH) Diagnostics Market Outlook to 2035 - Product Thumbnail Image

Global Nonalcoholic Steatohepatitis (NASH) Diagnostics Market Outlook to 2035

  • Report
  • March 2023
  • 189 Pages
  • Global
From
Liver Disease Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Liver Disease Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • July 2024
  • 150 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028) - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

  • Report
  • April 2023
  • 114 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Hepatic Encephalopathy Global Market Report 2024 - Product Thumbnail Image

Hepatic Encephalopathy Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
NASH Treatment & Therapeutics Market Report 2023-2033 - Product Thumbnail Image

NASH Treatment & Therapeutics Market Report 2023-2033

  • Report
  • July 2023
  • 224 Pages
  • Global
From
NASH Biomarkers (Non alcoholic Steatohepatitis) Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030 - Product Thumbnail Image

NASH Biomarkers (Non alcoholic Steatohepatitis) Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • Report
  • October 2023
  • 146 Pages
  • Global
From
Liver Failure (Hepatic Insufficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Liver Failure (Hepatic Insufficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 93 Pages
  • Global
From
Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021 - Product Thumbnail Image

Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) Market 2024-2028 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Market 2024-2028

  • Report
  • August 2024
  • 154 Pages
  • Global
From
Global Non-Alcoholic Steatohepatitis Market (by Drug Type, Application Type, Distribution Type, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027) - Product Thumbnail Image

Global Non-Alcoholic Steatohepatitis Market (by Drug Type, Application Type, Distribution Type, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)

  • Report
  • November 2023
  • 130 Pages
  • Global
From
Primary Biliary Cholangitis Therapeutics Market 2024-2028 - Product Thumbnail Image

Primary Biliary Cholangitis Therapeutics Market 2024-2028

  • Report
  • November 2023
  • 151 Pages
  • Global
From
Primary Biliary Cholangitis Therapeutics Market - Product Thumbnail Image

Primary Biliary Cholangitis Therapeutics Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
NASH Market - Analysis By Drug Type, Sales Chanel, By Region, By Country (2021 Edition): Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026) - Product Thumbnail Image

NASH Market - Analysis By Drug Type, Sales Chanel, By Region, By Country (2021 Edition): Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)

  • Report
  • March 2021
  • 210 Pages
  • Global
From
Primary biliary cirrhosis - Pipeline Insight, 2024 - Product Thumbnail Image

Primary biliary cirrhosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 120 Pages
  • Global
From
Primary Biliary Cholangitis Therapeutics Market By Drug type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

Primary Biliary Cholangitis Therapeutics Market By Drug type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • June 2023
  • 229 Pages
  • Global
From
Alcoholic Hepatitis Treatment Global Market Report 2024 - Product Thumbnail Image

Alcoholic Hepatitis Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Fatty Liver Treatment Global Market Report 2024 - Product Thumbnail Image

Fatty Liver Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Non-Alcoholic Steatohepatitis Treatment Global Market Report 2024 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Treatment Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Loading Indicator